Activities of Daily Living and Upper Extremity Exercise Capacity of Individuals with High Body Mass Index

Comparison of Activities of Daily Living and Upper Extremity Exercise Capacity of Individuals with High Body Mass Index with Those with Normal Body Mass Index

Individuals with high and normal body mass index will be included in this study.

Study Overview

• Status: Recruiting
• Conditions: Body Mass Index; Body Mass Index 25 or Greater; Body Mass Index, Normal

• Study Type: Observational
• Enrollment (Estimated): 24

Contacts and Locations

• Study Contact: Name: Merve Firat; Phone Number: +90 850 441 02 44; Email: mervefirat@ahievran.edu.tr

Study Locations

• Turkey
  • Kirsehir, Turkey
    • Recruiting
    • Kirsehir Ahi Evran University
    • Contact: Merve Firat; Phone Number: +90 850 441 02 44; Email: mervefirat@ahievran.edu.tr

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: Yes

• Sampling Method: Non-Probability Sample

Study Population

Individuals with high and normal body mass index will be included in the study.

Description

Inclusion Criteria for individuals with high body mass index:

• Body mass index ≥ 25 kg/m2
• Volunteering for the study

Exclusion Criteria for individuals with high body mass index:

• Having uncontrolled hypertension, diabetes mellitus
• Having comorbidities that may affect physical functions
• Failure to cooperate with tests to be performed
• Liver disease, kidney disease, cancer, lung diseases and serious cardiomyopathies, neurological diseases
• Pregnancy
• Having a history of bariatric surgery
• Presence of contraindications to exercise testing

Inclusion Criteria for individuals with normal body mass index:

• Body mass index 18.5-24.9 kg/m2
• Volunteering for the study

Exclusion Criteria for individuals with normal body mass index:

• Body mass index > 25 kg/m2 or ≤18.5 kg/m2
• Having a known chronic or systemic disease
• Failure to cooperate with tests to be performed

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort
Individuals with high body mass index
Individuals with normal body mass index

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Upper extremity exercise capacity	It will be assessed by 6 minute pegboard and ring test.	1st day
Daily living activities	It will be evaluated with the Glittre activities of daily living test.	1st day

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Fatigue	Fatigue will be assessed with a Fatigue Severity scale. The scale consists of 9 questions.The total score ranges from 9 to 63. An average score of 4 and above indicates severe fatigue.	1st day
Pain	It will be evaluated with the Nordic Musculoskeletal Questionnaire. It consists of 27 items that assess the presence of musculoskeletal symptoms over a 12-month period, covering nine different parts of the body. There are also items on functional status and the presence of musculoskeletal symptoms in the last 7 days. The total number of painful areas is determined. Total number of painful areas varies from 0-9.	1st day

Collaborators and Investigators

• Sponsor: Kirsehir Ahi Evran Universitesi

Study record dates

Study Major Dates

• Study Start (Actual): December 12, 2024
• Primary Completion (Estimated): May 1, 2025
• Study Completion (Estimated): December 1, 2025

Study Registration Dates

• First Submitted: December 17, 2024
• First Submitted That Met QC Criteria: December 17, 2024
• First Posted (Actual): March 25, 2025

Study Record Updates

• Last Update Posted (Actual): March 25, 2025
• Last Update Submitted That Met QC Criteria: December 17, 2024
• Last Verified: December 1, 2024

More Information

Terms related to this study

• Other Study ID Numbers: 2024-20/174

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No